rs11538884

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_012470.4(TNPO3):​c.2358G>A​(p.Leu786Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0477 in 1,613,690 control chromosomes in the GnomAD database, including 2,242 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.044 ( 206 hom., cov: 31)
Exomes 𝑓: 0.048 ( 2036 hom. )

Consequence

TNPO3
NM_012470.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.569

Publications

9 publications found
Variant links:
Genes affected
TNPO3 (HGNC:17103): (transportin 3) The protein encoded by this gene is a nuclear import receptor for serine/arginine-rich (SR) proteins such as the splicing factors SFRS1 and SFRS2. The encoded protein has also been shown to be involved in HIV-1 infection, apparently through interaction with the HIV-1 capsid protein. Several protein-coding and non-coding transcript variants have been found for this gene. [provided by RefSeq, Apr 2020]
TNPO3 Gene-Disease associations (from GenCC):
  • autosomal dominant limb-girdle muscular dystrophy type 1F
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 7-128972498-C-T is Benign according to our data. Variant chr7-128972498-C-T is described in ClinVar as Benign. ClinVar VariationId is 260264.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.569 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0762 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNPO3NM_012470.4 linkc.2358G>A p.Leu786Leu synonymous_variant Exon 19 of 23 ENST00000265388.10 NP_036602.1 Q9Y5L0-2A0A024R794B3KMX1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNPO3ENST00000265388.10 linkc.2358G>A p.Leu786Leu synonymous_variant Exon 19 of 23 1 NM_012470.4 ENSP00000265388.5 Q9Y5L0-2

Frequencies

GnomAD3 genomes
AF:
0.0443
AC:
6734
AN:
151842
Hom.:
205
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0175
Gnomad AMI
AF:
0.0318
Gnomad AMR
AF:
0.0340
Gnomad ASJ
AF:
0.0352
Gnomad EAS
AF:
0.0829
Gnomad SAS
AF:
0.0713
Gnomad FIN
AF:
0.113
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0479
Gnomad OTH
AF:
0.0413
GnomAD2 exomes
AF:
0.0521
AC:
13101
AN:
251272
AF XY:
0.0544
show subpopulations
Gnomad AFR exome
AF:
0.0174
Gnomad AMR exome
AF:
0.0207
Gnomad ASJ exome
AF:
0.0342
Gnomad EAS exome
AF:
0.0808
Gnomad FIN exome
AF:
0.105
Gnomad NFE exome
AF:
0.0477
Gnomad OTH exome
AF:
0.0488
GnomAD4 exome
AF:
0.0481
AC:
70285
AN:
1461730
Hom.:
2036
Cov.:
31
AF XY:
0.0490
AC XY:
35606
AN XY:
727154
show subpopulations
African (AFR)
AF:
0.0158
AC:
529
AN:
33474
American (AMR)
AF:
0.0216
AC:
966
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0337
AC:
880
AN:
26134
East Asian (EAS)
AF:
0.0785
AC:
3117
AN:
39692
South Asian (SAS)
AF:
0.0759
AC:
6548
AN:
86234
European-Finnish (FIN)
AF:
0.0990
AC:
5288
AN:
53398
Middle Eastern (MID)
AF:
0.0536
AC:
309
AN:
5768
European-Non Finnish (NFE)
AF:
0.0448
AC:
49769
AN:
1111928
Other (OTH)
AF:
0.0477
AC:
2879
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
3270
6540
9809
13079
16349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1828
3656
5484
7312
9140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0443
AC:
6732
AN:
151960
Hom.:
206
Cov.:
31
AF XY:
0.0478
AC XY:
3549
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.0174
AC:
723
AN:
41442
American (AMR)
AF:
0.0340
AC:
519
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.0352
AC:
122
AN:
3468
East Asian (EAS)
AF:
0.0827
AC:
427
AN:
5166
South Asian (SAS)
AF:
0.0720
AC:
344
AN:
4776
European-Finnish (FIN)
AF:
0.113
AC:
1197
AN:
10566
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.0479
AC:
3255
AN:
67966
Other (OTH)
AF:
0.0408
AC:
86
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
327
653
980
1306
1633
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0428
Hom.:
88
Bravo
AF:
0.0360
Asia WGS
AF:
0.0900
AC:
314
AN:
3478
EpiCase
AF:
0.0505
EpiControl
AF:
0.0481

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 26, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal dominant limb-girdle muscular dystrophy type 1F Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
8.7
DANN
Benign
0.82
PhyloP100
-0.57
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11538884; hg19: chr7-128612552; API